Drug Price Trends for CHLD ACETAMINOPHEN

Average Pharmacy Cost for CHLD ACETAMINOPHEN

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
CHLD ACETAMINOPHEN 160 MG/5 ML	00904-7014-16	0.01150	ML	2025-02-19
CHLD ACETAMINOPHEN 160 MG/5 ML	00904-6766-20	0.02065	ML	2025-02-19
CHLD ACETAMINOPHEN 160 MG/5 ML	45802-0203-26	0.02065	ML	2025-02-19

Market Analysis and Price Projections for Acetaminophen

Global Market Overview

The global acetaminophen market is poised for significant growth, driven by various factors including the increasing global population, rising incidence of chronic illnesses, and the need for effective pain management.

• The acetaminophen market was valued at USD 9.8 billion in 2022 and is expected to reach USD 15.2 billion by 2033, growing at a CAGR of 4.2% during the forecast period[4].
• By 2037, the market is projected to cross USD 19.19 billion, expanding at a CAGR of more than 4.5% between 2025 and 2037[1].

Key Drivers of Growth

Several factors are driving the growth of the acetaminophen market:

• Increasing Global Population: The global population is growing at a rate of nearly 1% annually, leading to a higher demand for healthcare services and medications like acetaminophen[1].
• Chronic Illnesses: The prevalence of chronic illnesses such as cancer, chronic obstructive pulmonary disease (COPD), and other conditions that require pain management is on the rise. This has increased the demand for acetaminophen as a first-line treatment for pain relief[4].
• Opioid Tolerance: The rising use of medications to address opioid tolerance and the overtreatment of pain is another significant driver. Acetaminophen is often used in combination with opioids to enhance pain management without increasing side effects[4].

Market Segmentation

The acetaminophen market can be segmented into various categories:

• Dosage Form: The market includes tablets, liquid suspensions, and other forms. The tablets segment is estimated to dominate over 57% of the market share by 2037[1].
• Route of Administration: The oral route of administration leads the market with a share of about 92.4% in 2022[4].
• Geographical Regions: North America is expected to account for the largest revenue share, approximately 37% by 2037, due to a robust healthcare infrastructure and significant investments in R&D. The Asia Pacific region, particularly China, is also expected to dominate with a 32% revenue share by 2037, driven by population growth and increasing health issues[1].

Regional Market Analysis

North America

• North America is anticipated to hold the largest revenue share due to its advanced healthcare infrastructure and significant investments in research and development. The region's focus on promoting quality health solutions further drives the market growth[1].

Asia Pacific

• The Asia Pacific region, especially China, is expected to exhibit substantial growth. China's growing population, increasing life expectancy, and rising burden of non-communicable diseases are key factors contributing to the demand for acetaminophen. By 2040, it is predicted that 28% of the Chinese population will be 60 years or older, necessitating ongoing pain management[4].

India

• India holds a significant share of the South Asia market and is projected to display lucrative growth during the forecast period. The country's large population and increasing awareness of pain management are driving factors[4].

Price Projections and Cost Analysis

Retail Prices

• The retail price of acetaminophen can vary significantly depending on the pharmacy and the form of the medication. For example, a 100-tablet bottle of acetaminophen can cost between $3.41 and $7.86 at different pharmacies[2].

Generic vs. Branded

• Acetaminophen is significantly cheaper than its branded version, Ofirmev. Using a savings card, the cost of acetaminophen can be reduced to as low as $2.52 for a 100-tablet bottle, compared to the retail price of $10.64[2].

Children’s and Infant Formulations

• Medications for infants and children are often more expensive than those for adults due to additional packaging and dispensing tools such as syringes and plastic measuring cups. For instance, an infant version of Tylenol can cost $8.79 for a 2-ounce bottle, while the adult version costs $4.99 for a larger quantity[5].

Market Challenges

Despite the growth prospects, the acetaminophen market faces several challenges:

• Competition: The market is highly competitive, especially in regions like China where there is stiff competition from various manufacturers[1].
• Regulatory Environment: Changes in regulatory policies and healthcare reforms can impact the market dynamics and pricing strategies[4].

Key Players

The acetaminophen market is dominated by several key players, including:

• Pfizer Inc.
• Sanofi
• Janssen Pharmaceuticals
• Bayer AG
• GlaxoSmithKline plc
• Bristol-Myers Squibb and Company
• Teva Pharmaceutical Industries Ltd
• Cardinal Health Inc.
• Perrigo Company
• Novartis AG
• Sun Pharmaceutical Industries Ltd
• Abbott
• Mallinckrodt Pharmaceuticals
• Procter & Gamble Company[4].

Consumer Behavior and Preferences

Consumers are increasingly looking for cost-effective and efficient pain relief solutions. The use of savings cards and generic prescriptions is on the rise as consumers seek to minimize healthcare costs.

"Acetaminophen is a generic prescription; Ofirmev is the branded version of Acetaminophen. The SingleCare cost for Acetaminophen is $2.52 per 0.3, 100 tablets Bottle, which usually is much cheaper than the retail price of Ofirmev but has the same active ingredients."[2]

Key Takeaways

• The global acetaminophen market is expected to grow significantly, driven by population growth, chronic illnesses, and the need for effective pain management.
• The market is segmented by dosage form, route of administration, and geographical regions, with North America and Asia Pacific being key regions.
• Generic acetaminophen is significantly cheaper than branded versions, making it a preferred choice for cost-conscious consumers.
• The market faces challenges such as competition and regulatory changes but is driven by the increasing demand for pain relief medications.

Frequently Asked Questions (FAQs)

1. What is the projected growth rate of the global acetaminophen market?

• The global acetaminophen market is expected to grow at a CAGR of 4.2% from 2023 to 2033 and more than 4.5% from 2025 to 2037[1][4].

2. Which region is expected to dominate the acetaminophen market?

• North America is expected to account for the largest revenue share, approximately 37% by 2037, followed by the Asia Pacific region[1].

3. Why are children’s and infant versions of acetaminophen more expensive?

• Children’s and infant versions of acetaminophen are more expensive due to additional packaging and dispensing tools such as syringes and plastic measuring cups[5].

4. What is the difference between generic and branded acetaminophen?

• Generic acetaminophen is significantly cheaper than its branded version, Ofirmev, and contains the same active ingredients[2].

5. What are the key drivers of demand for acetaminophen?

• The key drivers include the increasing global population, rising incidence of chronic illnesses, and the need for effective pain management without opioid tolerance[1][4].

Cited Sources

1. Research Nester: Acetaminophen Market Size & Share, Growth Trends 2037[1].
2. SingleCare: Acetaminophen Coupons & Prices[2].
3. Verified Market Research: Antipyretic Drugs for Children Market Size, Share & Forecast[3].
4. Future Market Insights: Acetaminophen Market Size, Share, Trends & Outlook - 2033[4].
5. ABC15: Why is medicine for infants and children more expensive? - ABC15[5].